发明名称 Hydrazinyl lipidoids and uses thereof
摘要 The present disclosure is directed to hydrazinyl lipidoids, formulations thereof further comprising at least one active agent, as well as methods of delivering the at least one active agent to a target organism.
申请公布号 US9409869(B1) 申请公布日期 2016.08.09
申请号 US201615095793 申请日期 2016.04.11
申请人 Preceres Inc. 发明人 Heidebrecht, Jr. Richard Wayne;Zhong Cheng
分类号 C07D233/52;C07D213/77;C07C243/16;C07C243/22;A01N25/00;A61K9/51;A61K31/713;A61K47/16;A61K47/22 主分类号 C07D233/52
代理机构 McCarter & English LLP 代理人 McCarter & English LLP
主权项 1. A hydrazinyl lipidoid of formula (X): wherein RA is hydrogen, an optionally substituted aliphatic group, an optionally substituted heteroaliphatic group, or a group of formula (XII): wherein R3 and R4 are, independently, hydrogen, an optionally substituted aliphatic group, or an optionally substituted heteroaliphatic group;R5 is an optionally substituted aliphatic group or an optionally substituted heteroaliphatic group; andX is O or N; RB is hydrogen, an optionally substituted aliphatic group, an optionally substituted heteroaliphatic group, an optionally substituted aryl group, an optionally substituted heteroaryl group, an optionally substituted cycloalkyl group, an optionally substituted heterocycloalkyl group, or a group of formula (XII), wherein R3, R4, R5, and X are as defined above; RC is hydrogen, an optionally substituted aliphatic group, or a group of formula (XII), wherein R3, R4, R5, and X are as defined above; and RD is a group of formula (XII), wherein R3, R4, R5, and X are as defined above; and wherein if RB is hydrogen, neither of RA and RC can also be hydrogen; any one or more of R3, R4, R5, and RC together with another R3, R4, or R5, or one of RA and RB optionally defines a carbocyclic or heterocyclic ring system; and RA and RB together optionally define a carbocyclic or heterocyclic ring system.
地址 Cambridge MA US